The North America Hydrogel-based Drug Delivery System Market is expected to witness market growth of 7.4% CAGR during the forecast period (2021-2027).
The growth of the hydrogel-based drug delivery system market is expected to witness a surge due to the factors like rising number of studies to improve hydrogel-based protein delivery, the growing prevalence of CNS disorders, and increasing investment in hydrogel-based drug delivery systems. European Union in 2021 announced the investment for 13 projects that include the making of a hyaluronan-based hydrogel system in mucosal drug delivery. The project is estimated to come to the market in Oct 2021 and is expected to continue in the next three years. These kinds of initiatives are projected to develop the latest hydrogel-based drug delivery systems, thus bolstering the market growth.
The presence of key market players in this region is pushing the regional hydrogel-based drug delivery system market forward. In addition, the prevalence of efficient reimbursement policies, which cover the cost of modern therapies, is contributing to propelling demand for hydrogel-based drug delivery systems across the region. The increasing number of clinical trials in this region is opening new growth prospects for the regional market growth.
Moreover, the increasing cases of various diseases like bacterial vaginosis, especially in the US are estimated to bolster the growth of the market during the forecast period. All these factors are motivating the companies to expand their regional market share and thus, fuel the growth of the hydrogel-based drug delivery system market in this region.
The US market dominated the North America Hybrid Market by Country in 2020, and is expected to continue to be a dominant market till 2027; thereby, achieving a market value of $361.3 Million by 2027. The Canada market is experiencing a CAGR of 10.8% during (2021 - 2027). Additionally, The Mexico market is expected to witness a CAGR of 10% during (2021 - 2027).
Based on Polymer Origin, the market is segmented into Synthetic, Natural and Hybrid. Based on Delivery Route, the market is segmented into Ocular, Subcutaneous, Oral Cavity, Topical and Other Delivery Routes. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Johnson & Johnson, Bausch Health Companies, Inc., Medtronic PLC, Galderma S.A., Endo International PLC, Ferring Holdings SA, Akorn Operating Company LLC, Tolmar Pharmaceuticals, Inc., Blairex Laboratories, Inc., and Ocular Therapeutix, Inc.
Scope of the Study
Market Segments Covered in the Report:
By Polymer Origin
- Synthetic
- Natural
- Hybrid
By Delivery Route
- Ocular
- Subcutaneous
- Oral Cavity
- Topical
- Other Delivery Routes
By Country
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- Johnson & Johnson
- Bausch Health Companies, Inc.
- Medtronic PLC
- Galderma S.A.
- Endo International PLC
- Ferring Holdings SA
- Akorn Operating Company LLC
- Tolmar Pharmaceuticals, Inc.
- Blairex Laboratories, Inc.
- Ocular Therapeutix, Inc.
Unique Offerings from the Publisher
- Exhaustive coverage
- The highest number of market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Companies Mentioned
- Johnson & Johnson
- Bausch Health Companies, Inc.
- Medtronic PLC
- Galderma S.A.
- Endo International PLC
- Ferring Holdings SA
- Akorn Operating Company LLC
- Tolmar Pharmaceuticals, Inc.
- Blairex Laboratories, Inc.
- Ocular Therapeutix, Inc.
Methodology
LOADING...
